Phaze Clinical Research

Phaze Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Phaze Clinical Research is a private, service-based CRO operating in Greece, offering end-to-end clinical research support. The company is ISO 9001:2015 certified and a founding member of the Hellenic Association of CROs, positioning it as an established local player. Its business model focuses on providing outsourced services for clinical trials, with a clear geographic niche in facilitating and managing studies within Greece. As a service provider, it is revenue-generating with no proprietary therapeutic pipeline of its own.

Clinical ResearchDrug Development

Technology Platform

Integrated clinical trial service offering and local operational expertise for the Greek market, including project management, monitoring, data management, and regulatory navigation.

Opportunities

Capitalizing on Greece's attractiveness for clinical trials (skilled investigators, patient population) and the growing trend of sponsor outsourcing.
Opportunity to act as a preferred local partner for international CROs and biopharma companies without a Greek presence.

Risk Factors

High dependence on the Greek market and economic conditions; intense competition from global and local CROs; operational risks related to trial delivery and client retention in a project-based business.

Competitive Landscape

Competes with large global CROs (e.g., IQVIA, ICON, PRA) that have global scale and may have local Greek offices, as well as other regional and local Greek CROs. Differentiation is based on deep local expertise, agility, and potentially cost-effectiveness as a specialized player.